Royal Bank of Canada’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.94M | Buy |
377,772
+255,312
| +208% | +$5.37M | ﹤0.01% | 1998 |
|
|
2025
Q1 | $2.01M | Buy |
122,460
+28,322
| +30% | +$464K | ﹤0.01% | 2663 |
|
|
2024
Q4 | $2.42M | Buy |
94,138
+12,159
| +15% | +$312K | ﹤0.01% | 2551 |
|
|
2024
Q3 | $2.6M | Sell |
81,979
-8,503
| -9% | -$269K | ﹤0.01% | 2474 |
|
|
2024
Q2 | $3.18M | Buy |
90,482
+36,758
| +68% | +$1.29M | ﹤0.01% | 2290 |
|
|
2024
Q1 | $2.36M | Buy |
53,724
+35,332
| +192% | +$1.55M | ﹤0.01% | 2484 |
|
|
2023
Q4 | $654K | Buy |
18,392
+10,557
| +135% | +$375K | ﹤0.01% | 3538 |
|
|
2023
Q3 | $211K | Buy |
7,835
+3,429
| +78% | +$92.3K | ﹤0.01% | 4281 |
|
|
2023
Q2 | $103K | Sell |
4,406
-22,826
| -84% | -$534K | ﹤0.01% | 4879 |
|
|
2023
Q1 | $373K | Buy |
27,232
+395
| +1% | +$5.41K | ﹤0.01% | 3765 |
|
|
2022
Q4 | $487K | Buy |
26,837
+26,385
| +5,837% | +$479K | ﹤0.01% | 3690 |
|
|
2022
Q3 | $6K | Sell |
452
-168
| -27% | -$2.23K | ﹤0.01% | 6171 |
|
|
2022
Q2 | $9K | Sell |
620
-1,413
| -70% | -$20.5K | ﹤0.01% | 5958 |
|
|
2022
Q1 | $23K | Sell |
2,033
-4,575
| -69% | -$51.8K | ﹤0.01% | 6046 |
|
|
2021
Q4 | $156K | Buy |
6,608
+3,084
| +88% | +$72.8K | ﹤0.01% | 5063 |
|
|
2021
Q3 | $90K | Buy |
3,524
+1,595
| +83% | +$40.7K | ﹤0.01% | 5269 |
|
|
2021
Q2 | $40K | Buy |
1,929
+235
| +14% | +$4.87K | ﹤0.01% | 5687 |
|
|
2021
Q1 | $40K | Buy |
1,694
+630
| +59% | +$14.9K | ﹤0.01% | 5524 |
|
|
2020
Q4 | $15K | Buy |
1,064
+1,040
| +4,333% | +$14.7K | ﹤0.01% | 5642 |
|
|
2020
Q3 | $0 | Buy |
+24
| New | – | ﹤0.01% | 6213 |
|